What is the prevalence of comorbidities in older adults, typically those 65 years or older, and how are they managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prevalence of Comorbidities in Older Adults

The prevalence of comorbidities increases dramatically with age, affecting approximately 67% of older adults overall, rising from 50% in those under 65 years to 81.5% in those 85 years and older. 1

Age-Stratified Prevalence Data

The burden of multiple chronic conditions follows a clear age gradient:

  • Adults under 65 years: 50% have multimorbidity (defined as ≥2 chronic conditions) 1
  • Adults aged 65-74 years: 62% have multimorbidity 1
  • Adults aged ≥85 years: 81.5% have multimorbidity 1
  • Overall prevalence in older adults: 67% have two or more chronic conditions, with 97.5% having at least one comorbidity 1, 2

Most Common Comorbid Conditions

Among older adults with chronic disease, the most prevalent conditions include:

  • Hypertension: 82.1% 2
  • Overweight/obesity: 78.2% 2
  • Hyperlipidemia: 77.2% 2
  • Chronic kidney disease: 24.1% 2
  • Cardiovascular disease: 21.6% 2
  • Diabetes: 20% 3
  • Coronary artery disease: 15% 3

Notably, 29% of community-dwelling older adults report having two or more of the major chronic conditions (hypertension, diabetes, coronary artery disease, cancer, cerebrovascular disease), while only 29% report none of these conditions 3.

Common Comorbidity Clusters

The highest co-prevalence patterns demonstrate predictable disease clustering:

  • Hypertension + hyperlipidemia: 67.5% 2
  • Overweight/obesity + hypertension: 66.0% 2
  • Overweight/obesity + hyperlipidemia: 62.5% 2
  • Hypertension + chronic kidney disease: 22.4% 2
  • Cardiovascular disease combinations: 20.1-20.2% with hyperlipidemia or hypertension 2

Significant comorbidity exists among hypertension, coronary artery disease, cerebrovascular disease, and diabetes, though cancer does not cluster with these conditions 3.

Risk Factors and Predictors

Increased education tends to be protective against comorbidity development 3. The effects of age, gender, and race vary depending on the specific condition being examined 3.

Specific disease relationships include:

  • Hypertension, cerebrovascular disease, and diabetes are independent risk factors for developing coronary artery disease 3
  • Diabetes is a specific risk factor for cerebrovascular disease 3

Clinical Impact on Management

Comorbidity burden directly influences therapeutic decision-making and treatment intensity. In adults aged 65-74 years with uncontrolled blood pressure, therapeutic inertia (failure to intensify treatment) increases with comorbidity number: 7% higher with 2 comorbidities, 8% higher with 3-4 comorbidities, and 15% higher with ≥5 comorbidities compared to those without comorbidities 4.

However, after age 75 years, the number of comorbidities no longer correlates with therapeutic inertia, suggesting clinicians may reach a ceiling effect in their reluctance to intensify treatment in the very elderly 4.

Mortality Implications

All major chronic conditions except hypertension independently predict 6-year mortality in older adults 3. The presence of comorbidity itself—regardless of specific conditions—is life-threatening and increases mortality risk 3.

Key Clinical Pitfalls

  • Men have higher comorbidity burden than women across age groups, requiring more aggressive screening and management 2
  • Comorbidity assessment must be comprehensive, as 88.5% of older adults have at least two chronic conditions requiring coordinated management 2
  • Therapeutic inertia remains common (79-84% of visits with uncontrolled blood pressure), even after quality improvement interventions 4

Related Questions

Can I use the Z00.01 code for a Medicare Advantage patient, specifically an older adult with potential multiple comorbidities, for an initial examination and treatment as part of a general health check-up?
What is the optimal management plan for an elderly patient with a history of stroke, type 2 diabetes mellitus, hypercholesterolemia, hypertension, and multiple comorbidities?
What is the correlation between age and polymorbidity in older adults, particularly those over 65 years old with multiple chronic conditions?
What about using Mineralocorticoid Receptor Antagonists (MRAs) for a patient with type 1 diabetes mellitus and impaired renal function who cannot tolerate ACE inhibitors or ARBs due to severe heartburn?
What is the appropriate management and diagnosis for a female patient with elevated Red Blood Cell (RBC) count, hyperferritinemia, elevated Hematocrit (Hct), elevated Hemoglobin (Hgb), and abnormal Mean Corpuscular Hemoglobin (MCH), with otherwise normal laboratory results?
What adjustments should be made to the treatment plan for a patient experiencing tremors while taking Invega Sustenna (paliperidone) 150 mg monthly, olanzapine 10 mg nightly, and Depakote (valproate) 1000 mg BID?
Can a full bladder exacerbate Restless Legs Syndrome (RLS) symptoms in patients?
How do you identify corneal involvement on fluorescent staining in a patient with symptoms such as painful eye movement and purulent discharge, possibly a contact lens wearer?
What are the diagnostic criteria for Major Depressive Disorder (MDD) as outlined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5 TR)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.